» Articles » PMID: 11199812

Parkinson's Disease and Sleep

Overview
Journal J Neurol
Specialty Neurology
Date 2001 Feb 24
PMID 11199812
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There are many reasons for patients with idiopathic Parkinson's disease to develop sleep disorders and subsequent daytime sleepiness. Important causes are reduction of total sleep duration and sleep efficiency, and an increase in respiratory and motor arousals. This daytime sleepiness at first glance seems different from the "sleep attacks" which caused motot vehicle mishaps reported recently in persons taking pramipexole and ropinirole. There is, however, only little evidence that we deal with a new phenomenon in a new clinical situation, i. e. cataplexy-like attacks after high doses of new non-ergot dopamine-agonists. Until now there is no single case of a proven cataplexy on one hand, and older dopamine agonists like pergolide as well as L-Dopa + carbidopa have been reported to induce sudden onsets of sleep, too.

Citing Articles

Significant potential of melatonin therapy in Parkinson's disease - a meta-analysis of randomized controlled trials.

Iftikhar S, Sameer H, Zainab Front Neurol. 2023; 14:1265789.

PMID: 37881313 PMC: 10597669. DOI: 10.3389/fneur.2023.1265789.


Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila.

Pfeiffenberger C, Allada R PLoS Genet. 2012; 8(10):e1003003.

PMID: 23055946 PMC: 3464197. DOI: 10.1371/journal.pgen.1003003.


Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Medeiros C, de Bruin P, Lopes L, Magalhaes M, de Lourdes Seabra M, de Bruin V J Neurol. 2007; 254(4):459-64.

PMID: 17404779 DOI: 10.1007/s00415-006-0390-x.


Dopamine is a regulator of arousal in the fruit fly.

Kume K, Kume S, Park S, Hirsh J, Jackson F J Neurosci. 2005; 25(32):7377-84.

PMID: 16093388 PMC: 6725300. DOI: 10.1523/JNEUROSCI.2048-05.2005.


Sleep attacks in patients taking dopamine agonists: review.

Homann C, Wenzel K, Suppan K, Ivanic G, Kriechbaum N, Crevenna R BMJ. 2002; 324(7352):1483-7.

PMID: 12077032 PMC: 116443. DOI: 10.1136/bmj.324.7352.1483.